Todd Lehman Joins LumaBridge as Vice President and Head of Business De...

Your unfiltered news center. ®

The world you see depends upon the news you get. ®

HOME

ARTS

RSS

Today's Date: April 26, 2024

Carbon Removal and Mariculture Legislation Moves Forward in California Assembly • Suzano 2023 annual report on Form 20-F • CareTrust REIT Sets First Quarter Earnings Call for Friday, May 3, 2024 • Greenberg Traurig is a Finalist for Legal Media Group's 2024 Women in Business Law EMEA Awards • L.A. Care and Blue Shield of California Promise Health Plans Celebrate New Community Resource Center in West Los Angeles, Highli • The Sallie Mae Fund Grants $75,000 to DC College Access Program to Support Higher Education Access and Completion • 29 London Partners With US Media Company Bobi Media to Strengthen Market Offering • Broadstone Net Lease Issues 2023 Sustainability Report • Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions • Crescent Point at Niantic Assisted Living Community Named One of the Country's Best by U.S. News & World Report for Third St • Toro Taxes, the Leading Latino Tax Franchise selects Trez, to power Payroll solutions • Latin America CDC a Must, say Public Health Leaders and AHF • Brothers to Host Grand Opening Event for JDog Junk Removal & Hauling Business on April 28th • Whitman-Walker Institute Applauds the Biden-Harris Administration for Finalizing Robust Affordable Care Act Nondiscrimination Pr • Chase Opens Innovative Branch in Bronx’s Grand Concourse Neighborhood • Badger Meter Declares Regular Quarterly Dividend • Getting Tattooed with Gay History • US Marine Corps Veteran to Celebrate Grand Opening of JDog Junk Removal & Hauling in Findlay on May 4th • Levy Konigsberg Files Lawsuits on Behalf of 25 Men Who Allege They Were Sexually Abused as Juveniles Across Four New Jersey Juve • Books-A-Million Launches Its 22nd Coffee for the Troops Donation Campaign

Todd Lehman Joins LumaBridge as Vice President and Head of Business Development

SAN ANTONIO , May 31 /Businesswire/ - LumaBridge, a clinical research organization (CRO) dedicated to discovering, developing, and testing emerging biotechnologies related to cancer therapies, today announced the appointment of Todd Lehman as Vice President and Head of Business Development.

Todd brings nearly 20 years of client services, commercial and clinical operations experience to LumaBridge. His expertise spans multiple therapeutic areas, with a particular emphasis on oncology and ophthalmology. Prior to joining LumaBridge, Todd held various leadership roles in operations and portfolio management with a focus on the biotech customer at PPD, a Thermo Fisher Scientific company. Prior to PPD, he led the Medical Affairs, Global Clinical & Regulatory Operations at Alcon Laboratories. Todd began his career in the clinical research industry in 2004 at Rx Development Resources, the CRO division of Sirion Therapeutics. Todd holds an M.S. in biomedical engineering and a B.S. in chemical engineering, from the University of South Florida.

"We are thrilled to welcome Todd to the LumaBridge team," said David Boyle, Chief Executive Officer of LumaBridge. "Todd's extensive experience in the industry will play a pivotal role in driving our next phase of growth as we continue to scale our clinical trial capabilities."

“I’m honored to be joining LumaBridge at this exciting stage of growth in the company’s evolution,” said Todd Lehman. “I look forward to supporting the continued efforts of our customers in bringing innovative solutions to oncology patients.”

About LumaBridge

LumaBridge is a specialty clinical research organization (CRO) focused on creating innovative clinical trial solutions for biopharma companies. Founded in 2014 as Cancer Insight, the company offers customized clinical trial guidance, strategic partnership, and personalized attention to each sponsor, accelerating the development of potential therapies.

LumaBridge builds on the success and experience of a seasoned team, led by Dr. George Peoples, to support drug development, accelerating therapies to patients and guiding biopharma companies through clinical and regulatory pathways. As part of their comprehensive CRO services, LumaBridge offers consultation on trial design and clinical development strategy.

For more information, visit lumabridge.com.